The UK medicines regulator, the MHRA, has updated the product information for healthcare professionals and patients regarding the "small risk of severe acute pancreatitis in patients taking GLP-1s." While rare, the sheer scale of GLP-1 use in the UK with one recent study suggesting 1.6 million adults had used them in the last 12 months, and 3.3 million were interested in trying them in the following year makes it important for clinicians and patients to be aware of the warning signs of pancreatitis, said the regulator
Trends in Cardiovascular Medicine, 33(3), 159-166
do not use if expired
Melanotan II is frequently referenced within peptide research alongside other melanocortin analogues and synthetic peptides, with researchers evaluating purity, sequence integrity, and supplier standards when sourcing compounds from UK peptide providers
You can truly unwind while we handle the science of your glow
Its antibacterial and skin-lightening properties help reduce pigmentation and dark spots